Basic demographics Number of patients
female 43 (93.5%)
median age 37 (21-82)
Re-vaccination status Re-vaccination status
tolerated re-vaccination 13
refered after 2nd. vaccination 3
showed similar tolerability 2
re-vaccination planned 2
re-vaccination denied 2
unknown status 24
Diagnostic test Number of patients with positive results
SPT Comirnaty® 1
IDT Comirnaty® 2
SPT Vaxzervia® 1
IDT Vaxzervia® 0
SPT Spikevax® 0
IDT Spikevax® 1
IDT Janssen® 0
SPT PEG2000 1
IDT PEG2000 4
SPT PEG6000 1
IDT PEG6000 2
SPT PS80 0
BAT - suspected SARS-Cov-2 vaccine 3